Profound Medical Corp.
US ˙ NasdaqCM ˙ CA74319B5027

SecurityPROF / Profound Medical Corp.
InstitutionBleichroeder LP
Latest Disclosed Ownership254,753 shares
Latest Disclosed Value $ 1,650,799
Bleichroeder LP ownership in PROF / Profound Medical Corp.

On May 14, 2026 - Bleichroeder LP filed a 13F-HR form disclosing ownership of 254,753 shares of Profound Medical Corp. (US:PROF) valued at $1,650,799 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 254,753 shares of Profound Medical Corp.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $1,668,632 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F PROFOUND MED COM NEW 74319B502 254,753 0 0.00 1,651 -17.66 0.2853
2026-02-13 2025-12-31 13F PROFOUND MED COM NEW 74319B502 254,753 71,420 38.96 2,005 123.66 0.3528
2025-11-14 2025-09-30 13F PROFOUND MED COM NEW 74319B502 183,333 0 0.00 896 -17.11 0.1748
2025-08-14 2025-06-30 13F PROFOUND MED COM NEW 74319B502 183,333 0 0.00 1,082 1.41 0.2659
2025-05-15 2025-03-31 13F PROFOUND MED COM NEW 74319B502 183,333 0 0.00 1,067 -22.53 0.2843
2025-02-14 2024-12-31 13F PROFOUND MED COM NEW 74319B502 183,333 50,000 37.50 1,377 29.69 0.3460
2024-11-13 2024-09-30 13F PROFOUND MED COM NEW 74319B502 133,333 0 0.00 1,061 -5.10 0.2856
2024-08-13 2024-06-30 13F PROFOUND MED COM NEW 74319B502 133,333 0 0.00 1,119 -1.67 0.3327
2024-05-14 2024-03-31 13F PROFOUND MED COM NEW 74319B502 133,333 0 0.00 1,137 0.53 0.2837
2024-02-12 2023-12-31 13F PROFOUND MED COM NEW 74319B502 133,333 133,333 1,132 0.2516
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.